Chat with us
Research Assistance
Online
  • Please enter your first name.

U.K. Research Antibodies Market Size & Outlook, 2026-2033

The research antibodies market in the UK is expected to reach a projected revenue of US$ 227.4 million by 2033. A compound annual growth rate of 12% is expected of the UK research antibodies market from 2026 to 2033.

  • Biotechnology
    • Antibody Production
      • Research Antibodies Market Outlook
Revenue, 2025 (US$M)
$93.8
Estimate, 2026 (US$M)
$102.7
Forecast, 2033 (US$M)
$227.4
CAGR, 2026 - 2033
12.0%
U.K. Research Antibodies Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Ask Prism AI anything about the research antibodies market

Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.

Every answer starts with GVR research, and every figure is cited.Explore Prism AI

UK research antibodies market highlights

  • The UK research antibodies market generated a revenue of USD 93.8 million in 2025 and is expected to reach USD 227.4 million by 2033.
  • The UK market is expected to grow at a CAGR of 12% from 2026 to 2033.
  • In terms of segment, monoclonal antibodies was the largest revenue generating specificity in 2025.
  • Monoclonal Antibodies is the most lucrative specificity segment registering the fastest growth during the forecast period.


Research antibodies market data book summary

Market revenue in 2025USD 93.8 million
Market revenue in 2033USD 227.4 million
Growth rate12% (CAGR from 2026 to 2033)
Largest segmentMonoclonal antibodies
Fastest growing segmentMonoclonal Antibodies
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPolyclonal Antibodies, Monoclonal Antibodies
Key market players worldwideAbcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group


Other key industry trends

  • In terms of revenue, UK accounted for 4.8% of the global research antibodies market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, UK research antibodies market is projected to lead the regional market in terms of revenue in 2033.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 227.4 million by 2033.

The market for research antibodies is anticipated to grow lucratively in UK owing to increase in contract development, manufacturing and research activities by key market players across the country. For instance, in November 2017, Fujifilm Corporation expanded its production capacity for monoclonal antibodies through establishing process development and GMP production sites in UK.

High demand for novel antibodies to aid in research activities is fueling the growth prospects for this market in the UK. Local presence of key market players such as Abcam in the UK that are consistently striving to expand their geographical reach is further anticipated to present with remunerative growth opportunities.

No credit card required*

Publish Date: Jun 22, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study
Turnaround
5–10 working days

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Research Antibodies Market Companies

NameProfile# EmployeesHQWebsite
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
Becton Dickinson & CoView profile 73,0001 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880www.bd.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Bio-Techne CorpView profile 3,050614 McKinley Place N.E., Minneapolis, MN, United States, 55413www.bio-techne.com
Abcam PLCView profile 1,760Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AXwww.abcam.com
PerkinElmerView profile 10001+Waltham, Massachusetts, United States, North Americawww.perkinelmer.com
Proteintech GroupView profile 251-500Rosamond, Illinois, United States, North Americawww.ptglab.com
Cell Signaling TechnologyView profile 501-1000Danvers, Massachusetts, United States, North Americawww.cellsignal.com

U.K. Research Antibodies Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Research Antibodies Market Outlook will help companies and investors design strategic landscapes.


Monoclonal Antibodies was the largest segment with a revenue share of 68.34% in 2025.

Horizon Databook has segmented the U.K. research antibodies market based on polyclonal antibodies, monoclonal antibodies covering the revenue growth of each sub-segment from 2021 to 2033.




The market for research antibodies is anticipated to grow lucratively in UK owing to increase in contract development, manufacturing and research activities by key market players across the country. For instance, in November 2017, Fujifilm Corporation expanded its production capacity for monoclonal antibodies through establishing process development and GMP production sites in UK.

High demand for novel antibodies to aid in research activities is fueling the growth prospects for this market in the UK. Local presence of key market players such as Abcam in the UK that are consistently striving to expand their geographical reach is further anticipated to present with remunerative growth opportunities.

  • U.K. Research Antibodies Market Specificity Outlook (Revenue, USD Million , 2021-2033)
    • Polyclonal Antibodies
    • Monoclonal Antibodies
  • U.K. Research Antibodies Market Product Outlook (Revenue, USD Million , 2021-2033)
    • Primary
    • Secondary
  • U.K. Research Antibodies Market Technology Outlook (Revenue, USD Million , 2021-2033)
    • Western blotting
    • Flow cytometry
    • Immunofluorescence
    • Immunohistochemistry
    • Immunoprecipitation
    • ELISA
    • Others Technology
  • U.K. Research Antibodies Market Source Outlook (Revenue, USD Million , 2021-2033)
    • Rabbit
    • Goat
    • Mice
    • Others Source
  • U.K. Research Antibodies Market Applications Outlook (Revenue, USD Million , 2021-2033)
    • Oncology
    • Stem Cells
    • Others Applications
    • Infectious Diseases
    • Immunology
    • Neurobiology
  • U.K. Research Antibodies Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • Contract Research Organizations
    • Pharma & Biotech Companies
    • Academic & Research Institutes

Reasons to subscribe to Research Antibodies Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Research Antibodies Market Outlook databook

  • Our clientele includes a mix of Research Antibodies Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Research Antibodies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Research Antibodies Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

U.K. Research Antibodies Market, 2021-2033 (US$M)

No Access Stack Chart

UK research antibodies market statistics, by specificity, 2021-2033 (US$M)

No Access Pie Chart

UK research antibodies market statistics, by specificity, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more